| Literature DB >> 31824609 |
Hanieh-Sadat Ejtahed1, Roya Kelishadi2, Shirin Hasani-Ranjbar1, Pooneh Angoorani1, Mohammad Esmaeil Motlagh3, Gita Shafiee4, Hasan Ziaodini5, Majzoubeh Taheri6, Mostafa Qorbani7,8, Ramin Heshmat4.
Abstract
Introduction: The purpose of this study was to obtain the cutoff points of visceral adiposity index (VAI), a new marker of indirect evaluation of visceral fat, to assess its association with metabolic syndrome (MetS) in a population of children and adolescents.Entities:
Keywords: Adolescents; Children; Metabolic Syndrome; Visceral Adiposity Index
Year: 2019 PMID: 31824609 PMCID: PMC6891043 DOI: 10.15171/jcvtr.2019.46
Source DB: PubMed Journal: J Cardiovasc Thorac Res ISSN: 2008-5117
Characteristics of the study population: the CASPIAN-V study
|
|
|
|
|
|
| Age (y) | 12.3 (12.2-12.4) | 12.4 (12.3-12.5) | 12.2 (12.1-12.3) | <0.001 |
| Weight (kg) | 41.4 (40.8-41.9) | 42.4 (41.6-43.2) | 40.4 (39.7-41.1) | <0.001 |
| Height (cm) | 146.6 (146.0-147.2) | 148.1 (147.3-148.9) | 144.9 (144.2-145.6) | <0.001 |
| BMI (kg/m2) | 18.5 (18.3-18.6) | 18.5 (18.3-18.7) | 18.5 (18.3-18.7) | 0.50 |
| Waist (cm) | 66.7 (66.3-67.1) | 67.6 (67.0-68.2) | 65.7 (65.2-66.2) | <0.001 |
| SBP (mm Hg) | 99.2 (98.8-99.6) | 99.5 (98.9-100.1) | 98.7 (98.1-99.3) | <0.001 |
| DBP (mm Hg) | 63.8 (63.5-64.1) | 64.1 (63.6-64.6) | 63.5 (63.0-64.0) | 0.004 |
| FBG (mg/dL) | 91.6 (91.2-92.0) | 92.1 (91.5-92.7) | 91.2 (90.7-91.7) | 0.027 |
| TG (mg/dL) | 88.0 (86.6-89.4) | 87.1 (85.1-89.1) | 89.0 (86.9-91.1) | 0.20 |
| TC (mg/dL) | 153.8 (152.9-154.7) | 152.9 (151.7-154.1) | 154.8 (153.6-156.0) | 0.03 |
| HDL-C (mg/dL) | 46.2 (45.9-46.5) | 46.2 (45.7-46.6) | 46.1 (45.6-46.5) | 0.80 |
| LDL-C (mg/dL) | 90.3 (89.6-91.0) | 89.3 (88.3-90.3) | 90.8 (89.8-91.8) | 0.03 |
| VAI | 1.29 (1.26-1.32) | 1.03 (0.99-1.06) | 1.58 (1.53-1.63) | <0.001 |
Data are expressed as mean (95% CI).
* P values compared the characteristics of between boys and girls using Independent samples t test.
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose; TC, total cholesterol; TG, triglycerides; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; VAI, visceral adiposity index.
Bivariate correlation coefficients between visceral adiposity index and metabolic characteristics: the CASPIAN-V study
|
|
|
|
|
| Weight (kg) | 0.07** | 0.12** | 0.08** |
| Height (cm) | 0.08** | 0.13** | 0.10** |
| BMI (kg/m2) | 0.38* | 0.59* | 0.33* |
| Waist (cm) | 0.15** | 0.20** | 0.17** |
| SBP (mm Hg) | 0.03 | 0.08** | 0.02 |
| DBP (mm Hg) | 0.04* | 0.07** | 0.03 |
| FBG (mg/dL) | 0.12** | 0.14** | 0.15** |
| TG (mg/dL) | 0.84** | 0.87** | 0.91** |
| TC (mg/dL) | 0.11** | 0.13** | 0.09** |
| HDL-C (mg/dL) | -0.48** | -0.49** | -0.53** |
| LDL-C (mg/dL) | 0.01 | 0.03 | -0.02 |
*P < 0.05. **P < 0.01 using Pearson correlation test.
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose; TC, total cholesterol; TG, triglycerides; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; VAI, visceral adiposity index.
Mean of visceral adiposity index by Mets and numbers of MetS components: the CASPIAN-V study
|
|
|
| ||||
| MetS | ||||||
| Yes | 2.60 (2.42-2.78) | 2.11 (1.87-2.35) | 3.27 (2.95-3.59) | |||
| No | 1.22 (1.19-1.25) | 0.96 (0.93-0.99) | 1.50 (1.46-1.54) | |||
|
| <0.001 | <0.001 | <0.001 | |||
| MetS components | ||||||
| 0 | 0.82 (0.80-0.84) | 0.62 (0.60-0.63) | 0.99 (0.97-1.01) | |||
| 1 | 1.22 (1.18-1.25) | 0.97 (0.94-1.00) | 1.54 (1.48-1.60) | |||
| 2 | 1.99 (1.91-2.07) | 1.54 (1.46-1.62) | 2.52 (2.38-2.65) | |||
| ≥3 | 2.60 (2.42-2.78) | 2.11 (1.87-2.35) | 3.27 (2.95-3.59) | |||
|
| <0.001 | <0.001 | <0.001 | |||
Data are expressed as mean (95% CI).
* P values compared the visceral adiposity index among groups using Independent samples t test or ANOVA.
Metabolic syndrome: ATP-III criteria; Abdominal obesity: WC> 90th percentile; Low HDL: HDL< 40 mg/dL (except in boys 15–19 y old, that cut-off was < 45 mg/dL); High TG: TG>100 mg/dL; High FBG: FBG > 100 mg/dL; High blood pressure: BP> 90th (adjusted by age, sex, height). MetS components: 0, no risk; 1, one risk; 2, two risks; ≥3, at least three risks.
Odds ratio and 95% confidence interval for cardiometabolic risk factors across tertile categories of visceral adiposity index: the CASPIAN-V
|
|
|
|
| |||
|
|
|
|
|
|
| |
| obesity | ||||||
| Tertile1 (reference) | ||||||
| Tertile2 | 0.89 | (0.69-1.15) | 0.92 | (0.70-1.22) | ||
| Tertile3 | 1.07 | (0.84-1.37) | 1.14 | (0.87-1.48) | ||
|
| 0.56 | 0.33 | ||||
| Abdominal obesity | ||||||
| Tertile1 (reference) | ||||||
| Tertile2 | 1.27 | (1.04-1.57) | 1.35 | (1.08-1.68) | ||
| Tertile3 | 1.69 | (1.39-2.07) | 1.77 | (1.43-2.20) | ||
|
| <0.001 | <0.001 | ||||
| Impaired fasting glucose | ||||||
| Tertile1(reference) | ||||||
| Tertile2 | 1.52 | (0.99-2.33) | 1.61 | (1.01-2.55) | 1.64 | (1.03-2.60) |
| Tertile3 | 1.99 | (1.33-3.01) | 1.98 | (1.27-3.09) | 2.00 | (1.28-3.13) |
|
| 0.001 | 0.003 | 0.002 | |||
| Low HDL-C | ||||||
| Tertile1(reference) | ||||||
| Tertile2 | 4.50 | (3.52-5.76) | 4.48 | (3.43-5.86) | 4.49 | (3.43-5.86) |
| Tertile3 | 15.92 | (12.53-20.22) | 15.93 | (12.28-20.67) | 15.93 | (12.27-20.66) |
|
| <0.001 | <0.001 | <0.001 | |||
|
| ||||||
| Tertile1(reference) | ||||||
| Tertile2 | 1.20 | (0.93-1.55) | 1.27 | (0.95-1.69) | 1.29 | (0.97-1.72) |
| Tertile3 | 1.03 | (0.78-1.34) | 1.15 | (0.86-1.53) | 1.14 | (0.85-1.53) |
|
| 0.84 | 0.36 | 0.38 | |||
| High LDL-C | ||||||
| Tertile1(reference) | ||||||
| Tertile2 | 1.26 | (1.02-1.54) | 1.33 | (1.06-1.66) | 1.33 | (1.06-1.66) |
| Tertile3 | 1.19 | (0.97-1.46) | 1.25 | (1.01-1.57) | 1.26 | (1.01-1.57) |
|
| 0.11 | 0.053 | 0.052 | |||
Model 1: Logistic regression crude model.
Model 2: Adjustment for age, sex, living area, socioeconomic status, physical activity, screen time.
Model 3: Additional adjustment for BMI.
Receiver operator curve for visceral adiposity index for identifying children with MetS: the CASPIAN-V study
|
|
|
|
| ||
| Boy | 7-18 year | 1.30 (1.05-1.55) | 76% (66%-86%) | 81% (72%-90%) | 85% (81%-89%) |
| 7-12 year | 1.34 (0.94-1.75) | 65% (47%-83%) | 85% (64%-100%) | 82% (75%-88%) | |
| 13-18 year | 1.58 (1.24-1.93) | 76% (63%-89%) | 87% (75%-99%) | 88% (83%-92%) | |
| Girl | 7-18 year | 1.78 (1.41-2.14) | 94% (86%-100%) | 74% (65%-83%) | 89% (87%-92%) |
| 7-12 year | 1.93 (1.57-2.29) | 91% (83%-99%) | 81% (73%-90%) | 91% (88%-94%) | |
| 13-18 year | 1.58 (1.24-1.93) | 76% (63%-89%) | 87% (75%-99%) | 88% (84%-92%) | |
|
Total | 7-18 year | 1.58 (1.52-1.65) | 79% (74%-86%) | 78% (75%-82%) | 84% (81%-87%) |
| 7-12 year | 1.59 (1.19-1.99) | 76% (64%-87%) | 81% (72%-89%) | 84% (79%-88%) | |
| 13-18 year | 1.58 (1.45-1.72) | 83% (76%-91%) | 77% (71%-83%) | 84% (81%-88%) |
CI: confidence interval; AUC: area under curve shown as percentage.
Metabolic syndrome: ATP-III criteria; Abdominal obesity: WC> 90th percentile; Low HDL: HDL< 40 mg/dL (except in boys 15–19 y old, that cut-off was < 45 mg/dL); High TG: TG>100 mg/dL; High FBG: FBG > 100 mg/dL; High blood pressure: BP> 90th percentile (adjusted by age, sex, height).
Figure. 1